首页 >
法规速递
-
Document: Business process description for quality defect and non-compliance management-2025/4/22
2025-04-23查看详情 > -
Document: European Medicines Agency decision CW/0001/2025 of 2 June 2025 on class waivers in accordance with Regulation EC No 1901-2006 of the European Parliament and of the Council-2025/6/3
2025-06-04查看详情 > -
Document: Clinical Trial Information System (CTIS) structured data form -– Notifications, Annual Safety Report (ASR) and results-2025/7/9
2025-07-10查看详情 > -
Page: Deferasirox product-specific bioequivalence guidance-2025/8/14
2025-08-15查看详情 > -
Document: List of medicinal products under additional monitoring-2025/9/26
2025-09-28查看详情 > -
Document: Adzynma : EPAR - Public assessment report-2025/11/4
2025-11-05查看详情 > -
Page: Website outages and upgrades-2025/12/4
2025-12-05查看详情 > -
Document: IRIS guide for applicants - How to create, submit and manage IRIS applications, for industry and individual applicants-2026/1/9
2026-01-12查看详情 > -
Page: CVMP recommendations on limited market classification and eligibility for authorisation under Article 23-2026/2/12
2026-02-13查看详情 > -
国家药监局综合司公开征求《关于加快推进药品追溯体系建设工作的通知（征求意见稿）》意见-2026/3/24
2026-03-25查看详情 >
